Literature DB >> 8664344

Angiotensin II induces TIMP-1 production in rat heart endothelial cells.

C C Chua1, R C Hamdy, B H Chua.   

Abstract

Angiotensin II (AII) was found to upregulate tissue inhibitor of metalloproteineses-1 (TIMP-1) gene expression in rat heart endothelial cells in a dose and time-dependent manner. The maximal stimulation of TIMP-1 mRNA was achieved by 2 h after the addition of AII. This effect was blocked by losartan, an AT1 receptor antagonist and by calphostin C, a protein kinase C inhibitor. Addition of cycloheximide superinduced and actinomycin D abolished the induction. These results suggest that AII stimulates TIMP-1 production by a protein kinase C dependent pathway which is dependent upon de novo RNA synthesis. Immunoprecipitation experiment showed an enhanced band of 28 kDa from the conditioned medium of AII-treated cultures. Immunoblot analysis revealed that TIMP-1 was detectable in the conditioned medium 4 h after AII stimulation. Since endothelial cells line the blood vessels and sense the rise in AII associated with hypertension, the TIMP-1 released by these cells may provide an initial trigger leading to cardiac fibrosis in angiotensin-renin dependent hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8664344     DOI: 10.1016/0167-4889(95)00205-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

2.  Angiotensin receptors as sensitive markers of acute bronchiole injury after lung transplantation.

Authors:  Maria Nataatmadja; Margaret Passmore; Fraser D Russell; Sulistiana Prabowo; Amanda Corley; John F Fraser
Journal:  Lung       Date:  2014-05-06       Impact factor: 2.584

Review 3.  Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.

Authors:  Faiez Zannad; Anca Radauceanu
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 4.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 5.  Thoracic aortic dissection: are matrix metalloproteinases involved?

Authors:  Xiaoming Zhang; Ying H Shen; Scott A LeMaire
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

6.  Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.

Authors:  Piet Finckenberg; Kaija Inkinen; Juhani Ahonen; Saara Merasto; Marjut Louhelainen; Heikki Vapaatalo; Dominik Müller; Detlev Ganten; Friedrich Luft; Eero Mervaala
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 7.  Role of angiotensin II in the evolution of diastolic heart failure.

Authors:  Kavitha M Chinnaiyan; Daniel Alexander; Peter A McCullough
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-12       Impact factor: 3.738

8.  Neutrophil-like cell membrane-coated siRNA of lncRNA AABR07017145.1 therapy for cardiac hypertrophy via inhibiting ferroptosis of CMECs.

Authors:  Pilong Shi; Minghui Li; Chao Song; Hanping Qi; Lina Ba; Yonggang Cao; Meitian Zhang; Yawen Xie; Jing Ren; Jiabi Wu; Ping Ren; Hongli Sun
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-03       Impact factor: 8.886

9.  Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance.

Authors:  Hamid Yaghooti; Mohsen Firoozrai; Soudabeh Fallah; Mohammad Reza Khorramizadeh
Journal:  Avicenna J Med Biotechnol       Date:  2010-04

Review 10.  The Peritoneal Membrane-A Potential Mediator of Fibrosis and Inflammation among Heart Failure Patients on Peritoneal Dialysis.

Authors:  Margarita Kunin; Pazit Beckerman
Journal:  Membranes (Basel)       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.